The EU’s leading states are to restart their roll-out of the Oxford-AstraZeneca Covid-19 vaccine after Europe’s medicines regulator concluded it was “safe and effective”.

The European Medicines Agency (EMA) reviewed the jab after 13 European countries suspended use of the vaccine over fears of a link to blood clots.

It found the jab was “not associated” with a higher risk of clots.